These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3558984)
1. Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure. Asanoi H; Sasayama S; Iuchi K; Kameyama T J Am Coll Cardiol; 1987 Apr; 9(4):865-71. PubMed ID: 3558984 [TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure. Sasayama S; Inoue M; Asanoi H; Kodama K; Hori M; Sakurai T; Kawai C Heart Vessels; 1986; 2(1):23-8. PubMed ID: 3722083 [TBL] [Abstract][Full Text] [Related]
3. Oral OPC-8212 for the treatment of congestive heart failure: hemodynamic improvement and increased exercise capacity. Inoue M; Kim BH; Hori M; Tsuneoka Y; Matsubara N; Kamada T; Kodama K; Naka M; Nanto S; Higashino Y Heart Vessels; 1986; 2(3):166-71. PubMed ID: 3793669 [TBL] [Abstract][Full Text] [Related]
4. Sustained inotropic effects of a new cardiotonic agent. OPC-8212 in patients with chronic heart failure. Asanoi H; Sasayama S; Kameyama T; Ishizaka S; Iuchi K Clin Cardiol; 1989 Mar; 12(3):133-8. PubMed ID: 2647327 [TBL] [Abstract][Full Text] [Related]
5. Direct myocardial effects of OPC-18790 in human heart failure: beneficial effects on contractile and diastolic function demonstrated by intracoronary infusion with pressure-volume analysis. MacGowan GA; Haber HL; Cowart TD; Tedesco C; Wu C; Feldman MD J Am Coll Cardiol; 1998 May; 31(6):1344-51. PubMed ID: 9581731 [TBL] [Abstract][Full Text] [Related]
6. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance. Starling MR Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265 [TBL] [Abstract][Full Text] [Related]
8. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure. Hoit BD; Burwig S; Eppert D; Bhat G; Walsh RA Am Heart J; 1994 Dec; 128(6 Pt 1):1156-63. PubMed ID: 7985596 [TBL] [Abstract][Full Text] [Related]
9. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure. Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735 [TBL] [Abstract][Full Text] [Related]
10. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure. Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672 [TBL] [Abstract][Full Text] [Related]
11. [Acute hemodynamic effects of alifedrine in patients with heart failure]. Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988 [TBL] [Abstract][Full Text] [Related]
12. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure. Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928 [TBL] [Abstract][Full Text] [Related]
13. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [TBL] [Abstract][Full Text] [Related]
14. OPC-8212 in the treatment of congestive heart failure: results of a pilot study. Kubo SH; Rector TS; Strobeck JE; Cohn JN Cardiovasc Drugs Ther; 1988 Dec; 2(5):653-60. PubMed ID: 3154640 [TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group. Cardiovasc Drugs Ther; 1990 Apr; 4(2):419-25. PubMed ID: 2285626 [TBL] [Abstract][Full Text] [Related]
17. A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment. Inoue M; Hori M; Yasuda H; Takishima T; Sugimoto T; Sasayama S; Sakurai T; Nonogi H; Kodama K; Kusukawa R Cardiovasc Drugs Ther; 1987 Aug; 1(2):169-75. PubMed ID: 3154320 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts. Kino M; Hirota Y; Yamamoto S; Sawada K; Moriguchi M; Kotaka M; Kubo S; Kawamura K Am J Cardiol; 1983 Mar; 51(5):802-10. PubMed ID: 6829441 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of OPC-8212, an inotropic agent, in patients with chronic congestive heart failure--a multiple dose evaluation on its effect and arrhythmogenesis]. Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y Kokyu To Junkan; 1988 Oct; 36(10):1125-31. PubMed ID: 3247528 [No Abstract] [Full Text] [Related]
20. Central and regional hemodynamic effects of flosequinan for congestive heart failure. Haas GJ; Binkley PF; Carpenter JA; Leier CV Am J Cardiol; 1989 Jun; 63(18):1354-9. PubMed ID: 2658526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]